Education
About Us
Working with TipRanks
Follow Us
Adhera Therapeutics Inc (ATRX)
:ATRX
ATRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.02
Previous CloseN/A
Volume29.00
Average Volume (3M)15.55K
Market Cap
$7.00
Enterprise Value$265.46M
Total Cash (Recent Filing)$32.39K
Total Debt (Recent Filing)$10.83M
Price to Earnings (P/E)―
Beta-2.35
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.25
Shares Outstanding7,220,900
10 Day Avg. Volume15,551
30 Day Avg. Volume15,551
Financial Highlights & Ratios
PEG Ratio0.84
Price to Book (P/B)-26.32
Price to Sales (P/S)0.00
P/FCF Ratio-29.78
Enterprise Value/Market Cap37.92M
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda48.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ATRX FAQ
What was Adhera Therapeutics Inc’s price range in the past 12 months?
Adhera Therapeutics Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Adhera Therapeutics Inc’s market cap?
Adhera Therapeutics Inc’s market cap is $7.00.
When is Adhera Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Adhera Therapeutics Inc’s earnings last quarter?
Adhera Therapeutics Inc released its earnings results on May 18, 2018. The company reported -$0.129 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.129.
Is Adhera Therapeutics Inc overvalued?
According to Wall Street analysts Adhera Therapeutics Inc’s price is currently Overvalued.
Does Adhera Therapeutics Inc pay dividends?
Adhera Therapeutics Inc does not currently pay dividends.
What is Adhera Therapeutics Inc’s EPS estimate?
Adhera Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adhera Therapeutics Inc have?
Adhera Therapeutics Inc has 7,220,900 shares outstanding.
What happened to Adhera Therapeutics Inc’s price movement after its last earnings report?
Adhera Therapeutics Inc reported an EPS of -$0.129 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Adhera Therapeutics Inc?
Currently, no hedge funds are holding shares in ATRX
Company Description
Adhera Therapeutics Inc
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Onconetix
―